Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers
Moody's Upgrades Sanofi's Ratings, Changes Outlook to Stable
Sanofi Approves 2024 Financials and Announces Dividend at AGM
6-K: Annual General Meeting of April 30, 2025
French Stocks Reverse Two-Session Winning Streak
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Sanofi Consumer Healthcare India Releases Q1 2025 Financial Results
Sanofi: Information Concerning the Total Number of Voting Rights and Shares - March 2025
Sanofi (ENXTPA:SAN) Announces €4 Per Share Dividend And New Compensation Committee Chair
Sanofi Treatment of Multiple Myeloma Granted FDA Orphan Status
Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing
FDA to Tighten Vaccine Approval Requirements: Reports
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Sanofi Completes Opella Transaction, Shifts Focus to Biopharma
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday Trading
Sanofi Closed Sale Of 50% Stake In Opella To CD&R For €10B
Press Release: Annual General Meeting of April 30, 2025
Press Release: Sanofi and CD&R Close Opella Transaction, Create Global Consumer Healthcare Leader
Regeneron Drops as Eylea Drives Q1 Miss
Sanofi, McLaren Racing Partner for Meningitis Awareness